The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
IDH1 status and survival benefit from surgical resection of enhancing and nonenhancing tumor in malignant astrocytomas.
Daniel P. Cahill
No relevant relationships to disclose
Jason Beiko
No relevant relationships to disclose
Dima Suki
No relevant relationships to disclose
Sujit S. Prabhu
No relevant relationships to disclose
Jeffrey Weinberg
No relevant relationships to disclose
Frederick F. Lang
No relevant relationships to disclose
Mark R. Gilbert
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Ganesh Rao
No relevant relationships to disclose
Ian E. McCutcheon
No relevant relationships to disclose
Kenneth D. Aldape
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Raymond Sawaya
No relevant relationships to disclose